Production (Stage)
Disc Medicine, Inc.
IRON
$53.71
$1.001.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.54% | -43.08% | -61.45% | -37.63% | -34.88% |
| Total Depreciation and Amortization | 48.51% | 56.00% | 72.00% | 87.88% | 5.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.81% | 106.94% | 243.82% | 20.39% | 181.76% |
| Change in Net Operating Assets | 23,972.73% | 209.41% | 307.85% | 171.52% | 99.85% |
| Cash from Operations | -42.05% | -27.86% | -28.80% | -9.94% | -11.84% |
| Capital Expenditure | -914.96% | -467.42% | 39.80% | -55.56% | -58.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -444,701.57% | -328,362.92% | -296,745.92% | -305,266.67% | -58.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 142.91% | -5.49% | -42.82% | -42.71% | -15.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.21% | -103.71% | -100.00% | -100.16% | -64.33% |
| Cash from Financing | 150.97% | -8.80% | -48.15% | -48.08% | -21.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -307.00% | -201.28% | -156.44% | -130.99% | -34.47% |